COMMUNIQUÉS West-GlobeNewswire

Semaglutide superior to dulaglutide on glucose control and weight loss in people with type 2 diabetes in SUSTAIN 7
16/08/2017
Bagsværd , Denmark, 16 August 2017 - Novo Nordisk today announced the SUSTAIN 7 trial results, demonstrating that people with type 2 diabetes treated with once-weekly semaglutide experienced superior reduction in HbA 1c [...]
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
16/08/2017
Information relative au nombre total de droits de vote et d'actions composant le capital social 16 août 2017 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de [...]
Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome Type A
16/08/2017
NEW YORK and CLEVELAND, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare [...]
Photocure ASA: Presentation of the second quarter and first half year 2017 results
16/08/2017
Photocure will present its second quarter and first half year report on Wednesday 23 August 2017 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will [...]
Vascular Dynamics annonce l'approbation de la FDA pour le lancement de l'essai CALM 2 pour le MobiusHD® System pour le traitement de l'hypertension artérielle résistante
16/08/2017
MOUNTAIN VIEW, Californie, 15 août 2017 (GLOBE NEWSWIRE) - Vascular Dynamics, Inc. (VDI), société privée de dispositifs médicaux développant de nouvelles solutions pour le traitement de l'hypertension, annonce aujourd' [...]
Curetis Announces Financial Results for the First Six Months of 2017
16/08/2017
Curetis Announces Financial Results for the First Six Months of 2017 - Further advancement of product pipeline and integration of GEAR and Gyronimo platforms - Expansion of global installed base to 161 as of June 30, [...]
NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY - 30 JUNE 2017 (UNAUDITED)
16/08/2017
Company announcement, Helsinki, 16 August 2017 at 9:00 am Company Highlights, January - June 2017 Patient enrolment for Nexstim's supplementary Phase III Trial in Stroke Rehabilitation (E-FIT) using its NBT ® system is [...]
Ascom Myco and Koutio Médipôle optimize care communications and responsiveness
16/08/2017
Enabled by the Ascom Myco smart device, the new Koutio Médipôle is realizing improved care delivery through seamless information flow from the point of care to anywhere. BAAR, Switzerland, Aug. 16, 2017 (GLOBE NEWSWIRE [...]
New ThromboGenics' Ocriplasmin Clinical and Health Economic Data Presented at ASRS 2017 Annual Scientific Meeting in Boston
16/08/2017
Leuven, Belgium, 16 August 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for diabetic eye disease, announced today that further ocriplasmin clinical and health [...]
Curetis Announces Management Board Changes
16/08/2017
Curetis Announces Management Board Changes - New roles for Andreas Boos, Chris Bernard and Dr. Achim Plum Amsterdam, the Netherlands, and Holzgerlingen, Germany, August 16, 2017; published at 7 am CET -- Curetis N.V. ( [...]
MDxHealth Notice of January-June 2017 Financial Results
16/08/2017
COMPANY ANNOUNCEMENT / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, August 16, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced that it will release its financial [...]
Avis de publication des résultats financiers de MDxHealth pour janvier-juin 2017
16/08/2017
Annonce d'entreprise / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE IRVINE, CALIFORNIE et HERSTAL, BELGIQUE - 07:00 CEST, le 16 août, 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé la publication le jeudi 31 [...]
H1 2017: Tecan with significant increase in order entry and strong sales growth in the Life Sciences Business
16/08/2017
Financial results for the first half of 2017 Order entry of CHF 291.2 million (H1 2016: CHF 250.6 million) Growth of 16.7% in local currencies or 16.2% in Swiss francs Double-digit increase in both business segments [...]
La société NGX Bio a réuni 3 millions $ pour financer sa croissance sur le marché du séquençage de l'ADN
16/08/2017
SAN FRANCISCO, le 15 août 2017 (GLOBE NEWSWIRE) - NGX Bio, Inc., ( www.NGXbio.com ), leader du marché dans la prestation de services en ligne dans le domaine du séquençage de l'ADN, a annoncé la finalisation d'une levée [...]
ObsEva Reports Second Quarter 2017 Financial Results and Provides Business Update
15/08/2017
- Patient Enrollment Progressing for late stage clinical programs in Assisted Reproductive Technology, Uterine Fibroids, and Endometriosis - Geneva, Switzerland and Boston, MA - August 15, 2017 - ObsEva SA (NASDAQ: OBSV [...]
Prothena to Present New Research on Cardiac Biomarker NT-proBNP in AL Amyloidosis at HFSA Annual Meeting
15/08/2017
Preclinical Research Demonstrating a Relationship Between Amyloid Light Chain Toxicity and NT-proBNP Production Clinical Outcomes Research Showing a Correlation between NT-proBNP and Health-related Quality of Life [...]
Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2018
15/08/2017
DUBLIN - August 15, 2017 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the first quarter fiscal year 2018 on Tuesday, August 22, 2017. A news release will be issued at [...]
NGX Bio Raises $3 Million to Fund Growth of Its DNA Sequencing Marketplace
15/08/2017
SAN FRANCISCO, Aug. 15, 2017 (GLOBE NEWSWIRE) -- NGX Bio, Inc., ( www.NGXbio.com ) the premier marketplace for online DNA sequencing services, announced it has closed a $3 million funding round. The round was led by 180 [...]
Overallotment option of 15% has been exercised
15/08/2017
Company announcement - No. 37/2017 Overallotment option of 15% has been exercised The 15% overallotment option in connection with Zealand Pharma A/S' initial public offering of American Depositary Shares on the Nasdaq [...]

Pages